Studying label-retaining pancreas cancer cells, Li and coworkers showed that PDPK1 is significantly upregulated in LRCCs compared to the non-LRCC fraction and that PDPK1 regulates survival and response to chemotherapy treatment in LRCCs, a finding also made by another group47,49. The gene discussed is PDPK1; the disease is pancreatic neoplasm.